Alvameline

Alvameline (Lu25-109) is a partial M1 agonist and M2/M3 antagonist.

Product Specifications

CAS Number

[120241-31-8]

Product Name Alternative

Lu 25-109

UNSPSC

12352005

Target

MAChR

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/Alvameline.html

Solubility

10 mM in DMSO

Smiles

CN1CCC=C(C2=NN(CC)N=N2)C1

Molecular Formula

C9H15N5

Molecular Weight

193.25

References & Citations

[1]Jensen KG, et al. In vitro metabolism of the M1-muscarinic agonist 5- (2-ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine by human hepatic cytochromes P-450 determined at pH 7.4 and 8.5. Drug Metab Dispos. 1999 Jan;27 (1) :125-32.|[2]Waldeck K, et al. Actions of the new antimuscarinic compound Alvameline on isolated human and pig detrusor. Neurourol Urodyn. 2002;21 (1) :92-8.|[3]Pike BR, et al. Chronic administration of a partial muscarinic M1 receptor agonist attenuates decreases in forebrain choline acetyltransferase immunoreactivity following experimental brain trauma. Exp Neurol. 1997 Sep;147 (1) :55-65.